Biomarkers of response and prognosis in TTP

Since first described, Thrombotic thrombocytopenic purpura (TTP) has been a very uncommon disease with a long history marked by periodic episodes in which new evidence and treatments have markedly changed the course of this once fatal disease. Some of the most recent developments offer novel and exciting approaches to both our understanding and management of TTP and indeed, to thrombosis in general. This paper aims to review some of the significant events leading to the relatively good outcome which patients can expect today.
Source: Transfusion and Apheresis Science - Category: Hematology Authors: Source Type: research